Malária transfusional nas américas: revisão sistemática

Detalhes bibliográficos
Autor(a) principal: Alho, Regina Claudia Reboucas Mendes
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da Universidade do Estado do Amazonas (UEA)
Texto Completo: https://ri.uea.edu.br/handle/riuea/2209
Resumo: Malaria is an infectious disease that has an acute clinical and is considered a major public health problem in tropical and subtropical areas. In 2013, the World Health Organization estimated that there were on average 207 million cases of malaria worldwide. The occurrence of transfusion-transmitted malaria depends on: i) the criteria established by the countries regarding the selection of donors, especially in endemic regions where the presence of semi-immune individuals with mild parasitemias; ii) Plasmodium survival in blood stored at 4°C; and iii) the low sensitivity of the tests used in the screening of blood banks. The objective of this work was to study the epidemiological characteristics of transfusion-transmitted malaria in the Americas. For that, we carried out a systematic review of the literature on scientific bases LILACS, PubMed and Web of Science. Total of 62 studies were included, regarding donor selection, serology and blood surveillance. We identified studies since 1943 to 2014, 53% of them have been conducted and published from nonendemic countries (United States), followed by 18% from Brazil. Studies were mostly (70%) descriptive, with case reports and surveys. The prevalent species in the Americas is the P. vivax and was the second species most involved in cases of transfusion malaria, being preceded by P. malariae. Considering the Brazilian legislation, the literature shows that there is need to implement laboratory tests with more sensitivity and specificity for Plasmodium identification in donated blood, as the use of NAT, which uses real-time PCR, research the parasite would gain significant in the prevention of transfusion-transmitted malaria.
id UEA_db5cef2e923124be639a093cc79dffd0
oai_identifier_str oai:ri.uea.edu.br:riuea/2209
network_acronym_str UEA
network_name_str Repositório Institucional da Universidade do Estado do Amazonas (UEA)
repository_id_str
spelling Malária transfusional nas américas: revisão sistemáticaTransfusion malaria in the Americas: a systematic reviewDoador de sangueMaláriaTransfusão de sangueHematologiaMalaria is an infectious disease that has an acute clinical and is considered a major public health problem in tropical and subtropical areas. In 2013, the World Health Organization estimated that there were on average 207 million cases of malaria worldwide. The occurrence of transfusion-transmitted malaria depends on: i) the criteria established by the countries regarding the selection of donors, especially in endemic regions where the presence of semi-immune individuals with mild parasitemias; ii) Plasmodium survival in blood stored at 4°C; and iii) the low sensitivity of the tests used in the screening of blood banks. The objective of this work was to study the epidemiological characteristics of transfusion-transmitted malaria in the Americas. For that, we carried out a systematic review of the literature on scientific bases LILACS, PubMed and Web of Science. Total of 62 studies were included, regarding donor selection, serology and blood surveillance. We identified studies since 1943 to 2014, 53% of them have been conducted and published from nonendemic countries (United States), followed by 18% from Brazil. Studies were mostly (70%) descriptive, with case reports and surveys. The prevalent species in the Americas is the P. vivax and was the second species most involved in cases of transfusion malaria, being preceded by P. malariae. Considering the Brazilian legislation, the literature shows that there is need to implement laboratory tests with more sensitivity and specificity for Plasmodium identification in donated blood, as the use of NAT, which uses real-time PCR, research the parasite would gain significant in the prevention of transfusion-transmitted malaria.A malária é uma doença infecciosa, que apresenta características clínicas de caráter agudo, sendo considerado um grave problema de saúde pública no mundo. Em 2013, a Organização Mundial de Saúde estimou que ocorreram aproximadamente 207 milhões de casos de malária no mundo. A malária, além da transmissão natural, pode ser adquirida através da transfusão de sangue e, esta transmissão depende de diversos fatores como: os critérios estabelecidos pelos países em relação a seleção de doadores, em especial nas regiões endêmicas onde há presença de indivíduos semi-imunes para malária e com baixo nível de parasitemia, além da característica do Plasmodium conseguir sobreviver em sangue estocado a 4o C e da baixa sensibilidade dos testes utilizados nas triagens dos hemocentros. O objetivo desse trabalho foi estudar as características epidemiológicas da malária transfusional nas Américas, para tal realizou-se uma revisão sistemática da literatura nas bases científicas LILACS, PUBMED e Web of Science. Na revisão foram incluídos 62 estudos que foram organizados nas categorias: triagem clínica-epidemiológica, triagem laboratorial e hemovigilância. Identificamos estudos de 1943 até 2014, 53% deles foram realizados e publicados por países não endêmicos (EUA), seguido de 18% do Brasil considerado endêmico. Com relação ao tipo de estudo 76% foram descritivos: relatos de casos e inquéritos; a espécie prevalente nas Américas é o P. vivax e foi a segunda espécie mais envolvida nos casos de malária transfusional, sendo precedida pelo P. malariae. Considerando a legislação brasileira, a literatura mostra que há necessidade de implantação de testes laboratoriais com mais especificidade e sensibilidade para identificação do Plasmódio no sangue doado, como o uso do NAT, que utiliza o PCR em tempo real, na investigação do parasita; isto permitiria um ganho considerável na prevenção da malária transfusionalUniversidade do Estado do AmazonasBrasilUEAPROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS APLICADAS Á HEMATOLOGIALacerda, Marcus Vinícius Guimarães deMonteiro, Wuelton MarceloLacerda, Marcus Vinícius Guimarães deAlho, Regina Claudia Reboucas Mendes2020-03-11T14:06:46Z2024-09-05T18:56:03Z2020-03-112020-03-11T14:06:46Z2015-11-25info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttps://ri.uea.edu.br/handle/riuea/2209por1. WHO. World malaria report 2013. World Health Organization; 2014. 2. Scopel KKG. Diversidade genética e reconhecimento imune de proteínas de superfície de merozoítos de plasmodium falciparum (msp-1 e msp-2) em indivíduos expostos à malária no brasil. 2007 [citado 13 de setembro de 2015]; Recuperado de: http://www.parasitologia.icb.ufmg.br/defesas/208D.PDF 3. Rocha MOC, Pedroso ERP. Fundamentos em Infectologia. 2009. 851-906 p. 4. (Brasil) M da S. Guia prático de tratamento da malária no Brasil. Ministério da Saúde Brasília; 2010. 5. Ferreira ARL. Pesquisa de anticorpos anti-Plasmodium spp em indivíduos com estadia em zona endémica de Malária. 2013 [citado 14 de setembro de 2015]; Recuperado de: https://repositorio.ul.pt/handle/10451/8935 6. Camargo EP. Malária, maleita, paludismo. Ciênc E Cult. 2003;55(1):26–9. 7. Neves DP. Parasitologia humana [Internet]. Atheneu; 2002 [citado 13 de setembro de 2015]. Recuperado de: http://bases.bireme.br/cgibin/wxislind.exe/iah/online/?IsisScript=iah/iah.xis&src=google&base=LILACS& lang=p&nextAction=lnk&exprSearch=328106&indexSearch=ID 8. Ferreira MU. Lacunas na área de pesquisa e desafios para o controle da malária no Brasil. Cad Saúde Pública. 2011;27(12):2284–5. 9. Langhorne J, Ndungu FM, Sponaas A-M, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol. 2008;9(7):725–32. 10. Katsuragawa TH, Cunha RP de A, Souza DCA de, Gil LHS, Cruz RBM, Silva AAE, et al. Malária e aspectos hematológicos em moradores da área de influência dos futuros reservatórios das hidrelétricas de Santo Antônio e Jirau, Rondônia, Brasil. Cad Saúde Pública. 2009;25:1486–92. 11. WHO. World malaria report 2012. World Health Organization; 2013. 12. Lacerda MVG de, Zackiewicz C, Alecrim WD, Alecrim M das GC. The neglected Plasmodium vivax: are researchers from endemic areas really concerned about new treatment options? Rev Soc Bras Med Trop. 2007;40(4):489–90. 13. Lacerda MV, Mourao MP, Alexandre MA, Siqueira AM, Magalhães BM, Martinez-Espinosa Filho FE, et al. Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Malar J. 2012;11(12):10–1186. 14. Kumar R, Agarwal D, Kumar P. Severe Plasmodium vivax Malaria in Children: An emerging threat. J Pediatr Sci ISSN 1309-1247 [Internet]. 2014 [citado 14 45 de setembro de 2015];6. Recuperado de: http://www.pediatricsciences.com/ojs/index.php?journal=jps&page=article&op =view&path%5B%5D=501 15. Lanca EF, Magalhaes BM, Vitor-Silva S, Siqueira AM, Benzecry SG, Alexandre MA, et al. Risk factors and characterization of Plasmodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon. PLoS One. 2012;7(4):e35406. 16. Lacerda MVG, Alexandre MAA, Santos PD, Arcanjo ARL, Alecrim WD, Alecrim MGC. Idiopathic thrombocytopenic purpura due to vivax malaria in the Brazilian Amazon. Acta Trop. 2004;90(2):187–90. 17. Victoria M, Victoria V, Coelho A, Santos L, Alecrim M. Púrpura Trombocitopênica em pacientes com malária por Plasmodium vivax: Relato de Caso. Rev Soc Bras Med Trop. 1998; 18. Alexandre MA, Ferreira CO, Siqueira AM, Magalhães BL, Mourão MPG, Lacerda MV, et al. Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis. 2010;16(10):1611. 19. Chavan YS. Can Plasmodium Vivax Cause Cerebral Malaria? [citado 13 de setembro de 2015]; Recuperado de: http://www.indianpediatrics.net/sep1996/791.pdf 20. Bircan Z, Kervancioğlu M, Soran M, Gönlüsen G, Tuncer I. Two cases of nephrotic syndrome and tertian malaria in south-eastern Anatolia. Pediatr Nephrol. 1997;11(1):78–9. 21. Torres JR, Perez H, Postigo MM, Silva JR. Acute non-cardiogenic lung injury in benign tertian malaria. The Lancet. 1997;350(9070):31–2. 22. Alecrim M das GC. Estudo clínico, resistência e polimorfismo parasitário na malaria pelo Plasmodium vivax, em Manaus-AM [Internet]. Universidade de Braília. Faculdade de Medicina; 2000 [citado 13 de setembro de 2015]. Recuperado de: http://bases.bireme.br/cgibin/wxislind.exe/iah/online/?IsisScript=iah/iah.xis&src=google&base=LILACS& lang=p&nextAction=lnk&exprSearch=317043&indexSearch=ID 23. Alexandre MAA, LACERDA M, ARCANJO A, BRAGA W, ALECRIM W, ALECRIM M. Estudo clínico e epidemiológico dos casos graves da malária vivax em pacientes atendidos na Fundação de Medicina Tropical do Amazonas, Brasil. Manaus Universidade Estado Amazon. 2004; 24. Lança E de FC. Crianças com diagnóstico de malária hospitalizadas em Unidades de Terapia Intensa na Amazônia Brasileira: um estudo caso – controle de crianças com Plasmodium vivax [Dissertação]. [Internet]. [Manaus, amazonas]: Universidade do Estado do Amazonas; 2011 [citado 13 de 46 setembro de 2015]. Recuperado de: http://www.pos.uea.edu.br/data/area/dissertacao/download/14-2.pdf 25. Naing C, Whittaker MA, Wai VN, Mak JW. Is Plasmodium vivax malaria a severe malaria?: a systematic review and meta-analysis. 2014 [citado 1 de novembro de 2015]; Recuperado de: http://dx.plos.org/10.1371/journal.pntd.0003071 26. Hamerschlak N, Saraiva JCP. Hemoterapia e doenças infecciosas [Internet]. Editora Manole; [citado 13 de setembro de 2015]. Recuperado de: https://books.google.com.br/books?hl=ptBR&lr=&id=mLEbCgAAQBAJ&oi=fnd&pg=PT9&dq=Hemoterapia+e+doen%C 3%A7as+infecciosas&ots=qXwsOAG1PO&sig=dPawzw2XovzX9Vpki4G9HLj 07vw 27. Bruce-Chwatt LJ. Transfusion malaria. Bull World Health Organ. 1974;50(3- 4):337. 28. Anthony CN, Lau Y-L, Sum J-S, Fong M-Y, Ariffin H, Zaw W-L, et al. Malaysian child infected with Plasmodium vivax via blood transfusion: a case report. Malar J. 2013;12(1):508–317. 29. Chattopadhyay R, Majam VF, Kumar S. Survival of Plasmodium falciparum in human blood during refrigeration. Transfusion (Paris). 2011;51(3):630–5. 30. Lozner EL, Newhouser LR. STUDIES ON THE TRANSMISSIBILITY OF MALARIA BY PLASMA TRANSFUSIONS. Am J Med Sci. 1943;206(2):141–6. 31. Ferreira-da-Cruz M de F, Teva A, da Cruz E, Espindola-Mendes LG dos. Inactivation of Plasmodium falciparum Parasites Using g-irradiation. Mem Inst Oswaldo Cruz Rio Jan. 1997;92(1):137–8. 32. Braz LM, Amato Neto V, Carignani FL, Fernández AO, Hamerschlak N, Zuanella LS, et al. Estudo sobre a eventual utilidade de raios gama na profilaxia da malária transmissivel por transfusão de sangue. Rev Soc Bras Med Trop. 1998;31(6):549–52. 33. Lustigman S, Ben-Hur E. Photosensitized inactivation of Plasmodium falciparum in human red cells by phthalocyanines. Transfusion (Paris). 1996;36(6):543–6. 34. Smith TG, Kain KC. Inactivation of Plasmodium falciparum by photodynamic excitation of Heme-cycle intermediates derived from d-aminolevulinic acid. J Infect Dis. 2004;190(1):184–91. 35. Keil SD, Kiser P, Sullivan JJ, Kong AS, Reddy HL, Avery A, et al. Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfusion (Paris). 2013;53(10):2278–86. 47 36. Amato Neto V, de Sant’Ana EJ, Pinto PLS, Moreira AAB, Duarte MIS, Campos R, et al. Estudo experimental sobre a possibilidade de prevenção da malária pós-transfusional, através do uso da violeta de genciana. Rev Saúde Pública. 1987;21(6):497–500. 37. Lacerda MVG, Monteiro WM, Alexandre MAA, Alho RRM, Kiesslich D, Fraiji NA. We need to talk more about transfusion-transmitted malaria in Plasmodium vivax endemic areas. Rev Bras Hematol E Hemoter. 2014;36(6):385–7. 38. Cardo LJ, Salata J, Wilder D. Removal of Plasmodium falciparum–infected red blood cells from whole blood by leukoreduction filters. Transfusion (Paris). 2009;49(2):337–46. 39. Scuracchio P, Vieira SD, Dourado DA, Bueno LM, Colella R, Ramos-Sanchez EM, et al. Transfusion-transmitted malaria: case report of asymptomatic donor harboring Plasmodium malariae. Rev Inst Med Trop Sao Paulo. 2011;53(1):55– 9. 40. Negi G, Gupta V, Srivastava V, Gaur DS. Malaria positivity among blood donors: an important index to assess blood safety. J Parasit Dis. 2014;38(1):1– 3. 41. Owusu-Ofori AK, Parry C, Bates I. Transfusion-transmitted malaria in countries where malaria is endemic: a review of the literature from sub-Saharan Africa. Clin Infect Dis. 2010;51(10):1192–8. 42. Kiesslich D, Araújo MA, Yurtsever SV, Torres K. Controle da malária póstransfusional na Amazônia Brasileira: proposta de modificação das normas técnicas. Inf Epidemiol SUS. 1999;8(2):53–7. 43. Freitas DRC, Duarte EC. Normative evaluation of blood banks in the Brazilian Amazon region in respect to the prevention of transfusion-transmitted malaria. Rev Bras Hematol E Hemoter. 2014;36(6):394–402. 44. O’Brien SF, Uzicanin S, Choquet K, Yi Q-L, Fan W, Goldman M. Impact of changes to policy for Mexican risk travel on Canadian blood donor deferrals. Blood Transfus. 2013;11(4):580. 45. Spencer B, Kleinman S, Custer B, Cable R, Wilkinson SL, Steele W, et al. Deconstructing the risk for malaria in United States donors deferred for travel to Mexico. Transfusion (Paris). 2011;51(11):2398–410. 46. Spencer B, Steele W, Custer B, Kleinman S, Cable R, Wilkinson S, et al. Risk for malaria in United States donors deferred for travel to malaria-endemic areas. Transfusion (Paris). 2009;49(11):2335–45. 47. O’Brien S, Fan W, Xi G, Yi Q-L, Fearon M, Goldman M. Donor loss due to malaria-risk travel deferral. Transfusion (Paris). 2008;48((2S)):62A. 48 48. Leiby DA, Nguyen ML, Notari EP. Impact of donor deferrals for malaria on blood availability in the United States. Transfusion (Paris). 2008;48(10):2222–8. 49. Katz LM, Kabat A. Return behavior of blood donors after expiration of a 1-year malarial travel deferral. Transfusion (Paris). 2007;47(2):356–7. 50. Spencer BR, Custer B, Kakaiya RM, Hillyer KL, Wilkinson SL, Gottschall JL, et al. Low risk for malaria transmission from presenting blood donors excluded for travel to Mexico. In: Transfusion. BLACKWELL PUBLISHING 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND; 2006. p. 27A – 27A. 51. Nahlen BL, Lobel HO, Cannon SE, Campbell CC. Reassessment of blood donor selection criteria for United States travelers to malarious areas. Transfusion (Paris). 1991;31(9):798–804. 52. Torres K, dos Santos Morescob MN, Salesa LR, da Silva Abranchesb J, Alexandred MAA, Malheirob A. Transfusion-transmitted malaria in endemic zone: epidemiological profile of blood donors at the Fundacão HEMOAM and use of rapid diagnostic tests for malaria screening in Manaus. Rev Bras Hematol Hemoter. 2014;36(4):269–74. 53. Maselli LM, Levy D, Laporta GZ, Monteiro AM, Fukuya LA, Ferreira-da-Cruz MF, et al. Detection of Plasmodium falciparum and Plasmodium vivax subclinical infection in non-endemic region: implications for blood transfusion and malaria epidemiology. Malar J. 2014;13(224):10–1186. 54. Nguyen ML, Goff T, Gibble J, Steele WR, Leiby DA. Analyzing actual risk in malaria-deferred donors through selective serologic testing. Transfusion (Paris). 2013;53(8):1736–43. 55. Batista-dos-Santos S, Raiol M, Santos S, Cunha MG, Ribeiro-dos-Santos Â. Real-time PCR diagnosis of Plasmodium vivax among blood donors. Malar J. 2012;11(345):10–1186. 56. Contreras CE, Donato M de, Rivas MA, Rodulfo H, Mora R, Batista ME, et al. Malaria seroprevalence in blood bank donors from endemic and non-endemic areas of Venezuela. Mem Inst Oswaldo Cruz. 2011;106(2):123–9. 57. Fugikaha É, Fornazari PA, Penhalbel R de SR, Lorenzetti A, Maroso RD, Amoras JT, et al. Molecular screening of Plasmodium sp. asymptomatic carriers among transfusion centers from Brazilian Amazon region. Rev Inst Med Trop São Paulo. 2007;49(1):1–4. 58. Torres KL, Figueiredo DV, Zalis MG, Daniel-Ribeiro CT, Alecrim W, de Fátima Ferreira-da-Cruz M. Standardization of a very specific and sensitive single PCR for detection of Plasmodium vivax in low parasitized individuals and its usefulness for screening blood donors. Parasitol Res. 2006;98(6):519–24. 49 59. Castillo C, Ramírez C. Tamización de malaria en donantes de sangre de Cali, Colombia. Biomédica. 2005;25(2):203–10. 60. Shehata N, Kohli M, Detsky A. The cost-effectiveness of screening blood donors for malaria by PCR. Transfusion (Paris). 2004;44(2):217–28. 61. Sáez-Alquézar A, Ramos AM, Di Santi SM, Branquinho MS, Kirchgatter K, Cordeiro IA, et al. Controle da malária transfusional em região endêmica e não endêmica do Brasil. Rev Soc Bras Med Trop. 1998;31(1):27–34. 62. Ferreira MU, Camargo LMA, Carvalho ME de, Ninomia RT, Garcia LAV, Santos FR dos. Prevalence and levels of IgG and IgM antibodies against Plasmodium falciparum and P. vivax in blood donors from Rondonia, Brazilian Amazon. Mem Inst Oswaldo Cruz. 1993;88(2):263–9. 63. Nunez L, Linares J, Perez AH. [Seroprevalence of antibodies against Plasmodium falciparum in volunteer donors from various cities in Venezuela]. Sangre (Barc). 1992;37(2):141–3. 64. de Morales PO, Duque E, Espinal CA, Guerra P. Aplicación del método ELISA para la detección de anticuerpos maláricos en donantes de sangre. Bol Oficina Sanit Panam. 1986;101(4):348–54. 65. de Morales PO, Espinal CA. Detección de anticuerpos antiplasmodium por ELISA en donantes de sangre. Biomédica. 1982;2(2):57–62. 66. Sulzer AJ, Wilson M. The indirect fluorescent antibody test for the detection of occult malaria in blood donors. Bull World Health Organ. 1971;45(3):375. 67. Cullen KA, Arguin PM. Malaria surveillance—United States, 2011. MMWR Surveill Summ. 2013;62(5):1–17. 68. Echeverri D, Barreto DK, Osorio L, Cortés A, Martínez E. Malaria por Plasmodium vivax transmitida por transfusión de un donante asintomático a un recién nacido prematuro. Biomédica. 2012;32:8–12. 69. Mali S, Tan, Katherine, Arguin PM. Malaria surveillance–United States, 2009. MMWR Surveill Summ. 2011;60(SS03):1–15. 70. Gonzalez C, Layon A, Arguin P, Barnwell J, Wilkins P, Leiby DA, et al. Transfusion-transmitted falciparum malaria from an asymptomatic donor. In: Transfusion. WILEY-BLACKWELL COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA; 2011. p. 197A – 197A. 71. Mali S, Steele S, Slutsker L, Arguin PM, others. Malaria surveillance–United States, 2007 [Internet]. Department of Health & Human Services, Centers for Disease Control and Prevention; 2009 [citado 12 de setembro de 2015]. Recuperado de: http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5802a1.htm?s 50 72. Kirchgatter K, Nogueira SL, Padilha A, Curado I, Boulos M, Di Santi SM. Lethal malaria caused by Plasmodium malariae in an asplenic patient in Brazil. BMJ. 2005;331(7516):576b. 73. Di Santi SM, Carvalho ME, Costa MJ, Kirchgatter K, Pereira BF, Toniolo C, et al. Malária transfusional causada por Plasmodium malariae transmitido por doador assintomático infectado na Mata Atlântica do Estado de São Paulo. In: XL Congresso da Sociedade Brasileira de Medicina Tropical e I Encontro de Medicina Tropical do Cone Sul. 2005. p. 6–10. 74. Shah S, Filler S, Causer LM, Rowe AK, Bloland PB, Barber AM, et al. Malaria surveillance–United States, 2002. Morb Mortal Wkly Rep Surveill Summ Wash DC 2002. 2004;53(1):21–34. 75. CDC C for D. Probable transfusion-transmitted malaria–Houston, Texas, 2003. MMWR Morb Mortal Wkly Rep. 2003;52(44):1075. 76. Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med. 2001;344(26):1973–8. 77. Slinger R, Giulivi A, Bodie-Collins M, Hindieh F, John RS, Sher G, et al. Transfusion-transmitted malaria in Canada. Can Med Assoc J. 2001;164(3):377–9. 78. MacArthur JR, Levin AR, Mungai M, Roberts J, Barber AM, Bloland PB, et al. Malaria surveillance—United States, 1997. CDC Surveill Summ MMWR March. 2001;30:50. 79. Mungai M, Roberts J, Barber AM, Williams HA, Ruebush TK, Chang MH. Malaria surveillance—United States, 1996. CDC Surveill Summ March 23 MMWR. 2001;50:1–22. 80. Williams HA, Roberts J, Kachur SP, Barber AM, Barat LM, Bloland PB, et al. Malaria surveillance—United States, 1995. MMWR CDC Surveill Summ. 1999;48(1):1–23. 81. CDC C for D. Transfusion-transmitted malaria–Missouri and Pennsylvania, 1996-1998. MMWR Morb Mortal Wkly Rep. 1999;48(12):253. 82. Kachur SP, Reller ME, Barber AM, Barat LM, Koumans EH, Parise ME, et al. Malaria surveillance–United States, 1994. MMWR CDC Surveill Summ Morb Mortal Wkly Rep CDC Surveill Summ Dis Control. 1997;46(5):1–18. 83. Barat LM, Zucker JR, Barber AM, Parise ME, Paxton LA, Roberts J, et al. Malaria surveillance—United States, 1993. MMWR CDC Surveill Summ. 1997;46(2):27–47. 51 84. Soto Cáceres V, Cumpa Suyón M. Malaria intrahospitalaria en el Hospital Nacional IPSS Almanzor Aguinaga Asenjo de Chiclayo. Bol Soc Peru Med Interna. 1993;6(4):127–8. 85. de Andrade JCR, Wanderley DMV. Malária induzida no estado de São Paulo, Brasil. Rev Soc Bras Med Trop. 1991;24(3):157–61. 86. Insausti CL de, Torres J. Malaria inducida en Venezuela, un problema recurrente: reporte de dos casos por transfusión de derivados sanguíneos. Bol Venez Infectol. 1990;2(1):41–2. 87. Ríos Fabra A, Vargas Arenas RE, Wuani Ettedgui H, Linares J. Paludismo posttransfusional: reporte de un caso y revisión de la literatura. Arch Hosp Vargas. 1986;28(3/4):165–8. 88. Olivares Lopez F, Cruz Carranza G, Pérez Rodríguez E, Camacho Gutiérrez GR. Paludismo inducido por transfusión de sangre. Análisis de 44 casos. Rev Medica Mex. 1985;23(2):153–7. 89. CDC C for DC. Transfusion malaria: serologic identification of infected donors– Pennsylvania, Georgia. MMWR Morb Mortal Wkly Rep. 1983;32(17):222. 90. Yarrish RL, Janas JS, Nosanchuk JS, Steigbigel RT, Nusbacher J. Transfusion malaria: treatment with exchange transfusion after delayed diagnosis. Arch Intern Med. 1982;142(1):187–8. 91. Joishy S, Lopez C. Transfusion-induced malaria in a splenectomized ßthalassemia major patient and review of blood donor screening methods. Am J Hematol. 1980;8:221–9. 92. Garfield MD, Ershler WB, Maki DG. Malaria transmission by platelet concentrate transfusion. JAMA. 1978;240(21):2285–6. 93. Sawyer DM, Wadsworth LD. Plasmodium ovale malaria in Canada following transfusion. Can Med Assoc J. 1977;117(8):923. 94. Olivares L, Perez R, Vargas D, Camacho G. Paludismo inducido. Olivares, LF; Perez, RG; Vargas, DR; Camacho, GM: Salud Púb Méx. 1977;19:701. 95. Najem GR, Sulzer AJ. Transfusion-Induced Malaria from an Asymptomatic Carrier. Transfusion (Paris). 1976;16(5):473–6. 96. Maulitz RM, Marr JS, Shookhoff HB. Transfusion malaria as a consequence of the 1974 war between Turkey and Greece–two cases. Am J Trop Med Hyg. 1976;25(1):1–4. 97. Alvarez C, Rodriguez E, Diaz H. Paludismo transmitido por transfusión de sangre em los niños. Salud Púb Méx. 1974;15:213. 52 98. Seeler RA, Miller RA, Lin C-H, Lin S-K. Transfusion-induced malaria: Plasmodium vivax in a 5-month-old child. Am J Dis Child. 1973;125(1):132–3. 99. Dover AS, Guinee VF. Malaria transmission by leukocyte component therapy. JAMA. 1971;217(12):1701–2. 100. Arriaga J, Ramirez I, Ruiloba B, Ortega P. Paludismo postransfusional. Arch Inst Cardiol Méx. 1970;40:396. 101. Brooks MH, Barry KG. Fatal transfusion malaria. Blood. 1969;34(6):806–10. 102. Fisher G, Schultz M. Unusual host-parasite relationship in blood-donors responsible for transfusion-induced falciparum malaria. The Lancet. 1969;294(7623):716–8. 103. Chojnacki RE, Brazinsky JH, Barrett Jr O. Transfusion-introduced falciparum malaria. N Engl J Med. 1968;279(18):984. 104. Fischer WJ, York CL. Quartan Malaria Occurring Subsequent to a Blood Transfusion: Report of a Case. N Engl J Med. 1946;235(12):411–3.Atribuição-NãoComercial-SemDerivados 3.0 Brasilinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da Universidade do Estado do Amazonas (UEA)instname:Universidade do Estado do Amazonas (UEA)instacron:UEA2024-09-25T21:22:12Zoai:ri.uea.edu.br:riuea/2209Repositório InstitucionalPUBhttps://ri.uea.edu.br/server/oai/requestbibliotecacentral@uea.edu.bropendoar:2024-09-25T21:22:12Repositório Institucional da Universidade do Estado do Amazonas (UEA) - Universidade do Estado do Amazonas (UEA)false
dc.title.none.fl_str_mv Malária transfusional nas américas: revisão sistemática
Transfusion malaria in the Americas: a systematic review
title Malária transfusional nas américas: revisão sistemática
spellingShingle Malária transfusional nas américas: revisão sistemática
Alho, Regina Claudia Reboucas Mendes
Doador de sangue
Malária
Transfusão de sangue
Hematologia
title_short Malária transfusional nas américas: revisão sistemática
title_full Malária transfusional nas américas: revisão sistemática
title_fullStr Malária transfusional nas américas: revisão sistemática
title_full_unstemmed Malária transfusional nas américas: revisão sistemática
title_sort Malária transfusional nas américas: revisão sistemática
author Alho, Regina Claudia Reboucas Mendes
author_facet Alho, Regina Claudia Reboucas Mendes
author_role author
dc.contributor.none.fl_str_mv Lacerda, Marcus Vinícius Guimarães de
Monteiro, Wuelton Marcelo
Lacerda, Marcus Vinícius Guimarães de
dc.contributor.author.fl_str_mv Alho, Regina Claudia Reboucas Mendes
dc.subject.por.fl_str_mv Doador de sangue
Malária
Transfusão de sangue
Hematologia
topic Doador de sangue
Malária
Transfusão de sangue
Hematologia
description Malaria is an infectious disease that has an acute clinical and is considered a major public health problem in tropical and subtropical areas. In 2013, the World Health Organization estimated that there were on average 207 million cases of malaria worldwide. The occurrence of transfusion-transmitted malaria depends on: i) the criteria established by the countries regarding the selection of donors, especially in endemic regions where the presence of semi-immune individuals with mild parasitemias; ii) Plasmodium survival in blood stored at 4°C; and iii) the low sensitivity of the tests used in the screening of blood banks. The objective of this work was to study the epidemiological characteristics of transfusion-transmitted malaria in the Americas. For that, we carried out a systematic review of the literature on scientific bases LILACS, PubMed and Web of Science. Total of 62 studies were included, regarding donor selection, serology and blood surveillance. We identified studies since 1943 to 2014, 53% of them have been conducted and published from nonendemic countries (United States), followed by 18% from Brazil. Studies were mostly (70%) descriptive, with case reports and surveys. The prevalent species in the Americas is the P. vivax and was the second species most involved in cases of transfusion malaria, being preceded by P. malariae. Considering the Brazilian legislation, the literature shows that there is need to implement laboratory tests with more sensitivity and specificity for Plasmodium identification in donated blood, as the use of NAT, which uses real-time PCR, research the parasite would gain significant in the prevention of transfusion-transmitted malaria.
publishDate 2015
dc.date.none.fl_str_mv 2015-11-25
2020-03-11T14:06:46Z
2020-03-11
2020-03-11T14:06:46Z
2024-09-05T18:56:03Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://ri.uea.edu.br/handle/riuea/2209
url https://ri.uea.edu.br/handle/riuea/2209
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv 1. WHO. World malaria report 2013. World Health Organization; 2014. 2. Scopel KKG. Diversidade genética e reconhecimento imune de proteínas de superfície de merozoítos de plasmodium falciparum (msp-1 e msp-2) em indivíduos expostos à malária no brasil. 2007 [citado 13 de setembro de 2015]; Recuperado de: http://www.parasitologia.icb.ufmg.br/defesas/208D.PDF 3. Rocha MOC, Pedroso ERP. Fundamentos em Infectologia. 2009. 851-906 p. 4. (Brasil) M da S. Guia prático de tratamento da malária no Brasil. Ministério da Saúde Brasília; 2010. 5. Ferreira ARL. Pesquisa de anticorpos anti-Plasmodium spp em indivíduos com estadia em zona endémica de Malária. 2013 [citado 14 de setembro de 2015]; Recuperado de: https://repositorio.ul.pt/handle/10451/8935 6. Camargo EP. Malária, maleita, paludismo. Ciênc E Cult. 2003;55(1):26–9. 7. Neves DP. Parasitologia humana [Internet]. Atheneu; 2002 [citado 13 de setembro de 2015]. Recuperado de: http://bases.bireme.br/cgibin/wxislind.exe/iah/online/?IsisScript=iah/iah.xis&src=google&base=LILACS& lang=p&nextAction=lnk&exprSearch=328106&indexSearch=ID 8. Ferreira MU. Lacunas na área de pesquisa e desafios para o controle da malária no Brasil. Cad Saúde Pública. 2011;27(12):2284–5. 9. Langhorne J, Ndungu FM, Sponaas A-M, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol. 2008;9(7):725–32. 10. Katsuragawa TH, Cunha RP de A, Souza DCA de, Gil LHS, Cruz RBM, Silva AAE, et al. Malária e aspectos hematológicos em moradores da área de influência dos futuros reservatórios das hidrelétricas de Santo Antônio e Jirau, Rondônia, Brasil. Cad Saúde Pública. 2009;25:1486–92. 11. WHO. World malaria report 2012. World Health Organization; 2013. 12. Lacerda MVG de, Zackiewicz C, Alecrim WD, Alecrim M das GC. The neglected Plasmodium vivax: are researchers from endemic areas really concerned about new treatment options? Rev Soc Bras Med Trop. 2007;40(4):489–90. 13. Lacerda MV, Mourao MP, Alexandre MA, Siqueira AM, Magalhães BM, Martinez-Espinosa Filho FE, et al. Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Malar J. 2012;11(12):10–1186. 14. Kumar R, Agarwal D, Kumar P. Severe Plasmodium vivax Malaria in Children: An emerging threat. J Pediatr Sci ISSN 1309-1247 [Internet]. 2014 [citado 14 45 de setembro de 2015];6. Recuperado de: http://www.pediatricsciences.com/ojs/index.php?journal=jps&page=article&op =view&path%5B%5D=501 15. Lanca EF, Magalhaes BM, Vitor-Silva S, Siqueira AM, Benzecry SG, Alexandre MA, et al. Risk factors and characterization of Plasmodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon. PLoS One. 2012;7(4):e35406. 16. Lacerda MVG, Alexandre MAA, Santos PD, Arcanjo ARL, Alecrim WD, Alecrim MGC. Idiopathic thrombocytopenic purpura due to vivax malaria in the Brazilian Amazon. Acta Trop. 2004;90(2):187–90. 17. Victoria M, Victoria V, Coelho A, Santos L, Alecrim M. Púrpura Trombocitopênica em pacientes com malária por Plasmodium vivax: Relato de Caso. Rev Soc Bras Med Trop. 1998; 18. Alexandre MA, Ferreira CO, Siqueira AM, Magalhães BL, Mourão MPG, Lacerda MV, et al. Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis. 2010;16(10):1611. 19. Chavan YS. Can Plasmodium Vivax Cause Cerebral Malaria? [citado 13 de setembro de 2015]; Recuperado de: http://www.indianpediatrics.net/sep1996/791.pdf 20. Bircan Z, Kervancioğlu M, Soran M, Gönlüsen G, Tuncer I. Two cases of nephrotic syndrome and tertian malaria in south-eastern Anatolia. Pediatr Nephrol. 1997;11(1):78–9. 21. Torres JR, Perez H, Postigo MM, Silva JR. Acute non-cardiogenic lung injury in benign tertian malaria. The Lancet. 1997;350(9070):31–2. 22. Alecrim M das GC. Estudo clínico, resistência e polimorfismo parasitário na malaria pelo Plasmodium vivax, em Manaus-AM [Internet]. Universidade de Braília. Faculdade de Medicina; 2000 [citado 13 de setembro de 2015]. Recuperado de: http://bases.bireme.br/cgibin/wxislind.exe/iah/online/?IsisScript=iah/iah.xis&src=google&base=LILACS& lang=p&nextAction=lnk&exprSearch=317043&indexSearch=ID 23. Alexandre MAA, LACERDA M, ARCANJO A, BRAGA W, ALECRIM W, ALECRIM M. Estudo clínico e epidemiológico dos casos graves da malária vivax em pacientes atendidos na Fundação de Medicina Tropical do Amazonas, Brasil. Manaus Universidade Estado Amazon. 2004; 24. Lança E de FC. Crianças com diagnóstico de malária hospitalizadas em Unidades de Terapia Intensa na Amazônia Brasileira: um estudo caso – controle de crianças com Plasmodium vivax [Dissertação]. [Internet]. [Manaus, amazonas]: Universidade do Estado do Amazonas; 2011 [citado 13 de 46 setembro de 2015]. Recuperado de: http://www.pos.uea.edu.br/data/area/dissertacao/download/14-2.pdf 25. Naing C, Whittaker MA, Wai VN, Mak JW. Is Plasmodium vivax malaria a severe malaria?: a systematic review and meta-analysis. 2014 [citado 1 de novembro de 2015]; Recuperado de: http://dx.plos.org/10.1371/journal.pntd.0003071 26. Hamerschlak N, Saraiva JCP. Hemoterapia e doenças infecciosas [Internet]. Editora Manole; [citado 13 de setembro de 2015]. Recuperado de: https://books.google.com.br/books?hl=ptBR&lr=&id=mLEbCgAAQBAJ&oi=fnd&pg=PT9&dq=Hemoterapia+e+doen%C 3%A7as+infecciosas&ots=qXwsOAG1PO&sig=dPawzw2XovzX9Vpki4G9HLj 07vw 27. Bruce-Chwatt LJ. Transfusion malaria. Bull World Health Organ. 1974;50(3- 4):337. 28. Anthony CN, Lau Y-L, Sum J-S, Fong M-Y, Ariffin H, Zaw W-L, et al. Malaysian child infected with Plasmodium vivax via blood transfusion: a case report. Malar J. 2013;12(1):508–317. 29. Chattopadhyay R, Majam VF, Kumar S. Survival of Plasmodium falciparum in human blood during refrigeration. Transfusion (Paris). 2011;51(3):630–5. 30. Lozner EL, Newhouser LR. STUDIES ON THE TRANSMISSIBILITY OF MALARIA BY PLASMA TRANSFUSIONS. Am J Med Sci. 1943;206(2):141–6. 31. Ferreira-da-Cruz M de F, Teva A, da Cruz E, Espindola-Mendes LG dos. Inactivation of Plasmodium falciparum Parasites Using g-irradiation. Mem Inst Oswaldo Cruz Rio Jan. 1997;92(1):137–8. 32. Braz LM, Amato Neto V, Carignani FL, Fernández AO, Hamerschlak N, Zuanella LS, et al. Estudo sobre a eventual utilidade de raios gama na profilaxia da malária transmissivel por transfusão de sangue. Rev Soc Bras Med Trop. 1998;31(6):549–52. 33. Lustigman S, Ben-Hur E. Photosensitized inactivation of Plasmodium falciparum in human red cells by phthalocyanines. Transfusion (Paris). 1996;36(6):543–6. 34. Smith TG, Kain KC. Inactivation of Plasmodium falciparum by photodynamic excitation of Heme-cycle intermediates derived from d-aminolevulinic acid. J Infect Dis. 2004;190(1):184–91. 35. Keil SD, Kiser P, Sullivan JJ, Kong AS, Reddy HL, Avery A, et al. Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfusion (Paris). 2013;53(10):2278–86. 47 36. Amato Neto V, de Sant’Ana EJ, Pinto PLS, Moreira AAB, Duarte MIS, Campos R, et al. Estudo experimental sobre a possibilidade de prevenção da malária pós-transfusional, através do uso da violeta de genciana. Rev Saúde Pública. 1987;21(6):497–500. 37. Lacerda MVG, Monteiro WM, Alexandre MAA, Alho RRM, Kiesslich D, Fraiji NA. We need to talk more about transfusion-transmitted malaria in Plasmodium vivax endemic areas. Rev Bras Hematol E Hemoter. 2014;36(6):385–7. 38. Cardo LJ, Salata J, Wilder D. Removal of Plasmodium falciparum–infected red blood cells from whole blood by leukoreduction filters. Transfusion (Paris). 2009;49(2):337–46. 39. Scuracchio P, Vieira SD, Dourado DA, Bueno LM, Colella R, Ramos-Sanchez EM, et al. Transfusion-transmitted malaria: case report of asymptomatic donor harboring Plasmodium malariae. Rev Inst Med Trop Sao Paulo. 2011;53(1):55– 9. 40. Negi G, Gupta V, Srivastava V, Gaur DS. Malaria positivity among blood donors: an important index to assess blood safety. J Parasit Dis. 2014;38(1):1– 3. 41. Owusu-Ofori AK, Parry C, Bates I. Transfusion-transmitted malaria in countries where malaria is endemic: a review of the literature from sub-Saharan Africa. Clin Infect Dis. 2010;51(10):1192–8. 42. Kiesslich D, Araújo MA, Yurtsever SV, Torres K. Controle da malária póstransfusional na Amazônia Brasileira: proposta de modificação das normas técnicas. Inf Epidemiol SUS. 1999;8(2):53–7. 43. Freitas DRC, Duarte EC. Normative evaluation of blood banks in the Brazilian Amazon region in respect to the prevention of transfusion-transmitted malaria. Rev Bras Hematol E Hemoter. 2014;36(6):394–402. 44. O’Brien SF, Uzicanin S, Choquet K, Yi Q-L, Fan W, Goldman M. Impact of changes to policy for Mexican risk travel on Canadian blood donor deferrals. Blood Transfus. 2013;11(4):580. 45. Spencer B, Kleinman S, Custer B, Cable R, Wilkinson SL, Steele W, et al. Deconstructing the risk for malaria in United States donors deferred for travel to Mexico. Transfusion (Paris). 2011;51(11):2398–410. 46. Spencer B, Steele W, Custer B, Kleinman S, Cable R, Wilkinson S, et al. Risk for malaria in United States donors deferred for travel to malaria-endemic areas. Transfusion (Paris). 2009;49(11):2335–45. 47. O’Brien S, Fan W, Xi G, Yi Q-L, Fearon M, Goldman M. Donor loss due to malaria-risk travel deferral. Transfusion (Paris). 2008;48((2S)):62A. 48 48. Leiby DA, Nguyen ML, Notari EP. Impact of donor deferrals for malaria on blood availability in the United States. Transfusion (Paris). 2008;48(10):2222–8. 49. Katz LM, Kabat A. Return behavior of blood donors after expiration of a 1-year malarial travel deferral. Transfusion (Paris). 2007;47(2):356–7. 50. Spencer BR, Custer B, Kakaiya RM, Hillyer KL, Wilkinson SL, Gottschall JL, et al. Low risk for malaria transmission from presenting blood donors excluded for travel to Mexico. In: Transfusion. BLACKWELL PUBLISHING 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND; 2006. p. 27A – 27A. 51. Nahlen BL, Lobel HO, Cannon SE, Campbell CC. Reassessment of blood donor selection criteria for United States travelers to malarious areas. Transfusion (Paris). 1991;31(9):798–804. 52. Torres K, dos Santos Morescob MN, Salesa LR, da Silva Abranchesb J, Alexandred MAA, Malheirob A. Transfusion-transmitted malaria in endemic zone: epidemiological profile of blood donors at the Fundacão HEMOAM and use of rapid diagnostic tests for malaria screening in Manaus. Rev Bras Hematol Hemoter. 2014;36(4):269–74. 53. Maselli LM, Levy D, Laporta GZ, Monteiro AM, Fukuya LA, Ferreira-da-Cruz MF, et al. Detection of Plasmodium falciparum and Plasmodium vivax subclinical infection in non-endemic region: implications for blood transfusion and malaria epidemiology. Malar J. 2014;13(224):10–1186. 54. Nguyen ML, Goff T, Gibble J, Steele WR, Leiby DA. Analyzing actual risk in malaria-deferred donors through selective serologic testing. Transfusion (Paris). 2013;53(8):1736–43. 55. Batista-dos-Santos S, Raiol M, Santos S, Cunha MG, Ribeiro-dos-Santos Â. Real-time PCR diagnosis of Plasmodium vivax among blood donors. Malar J. 2012;11(345):10–1186. 56. Contreras CE, Donato M de, Rivas MA, Rodulfo H, Mora R, Batista ME, et al. Malaria seroprevalence in blood bank donors from endemic and non-endemic areas of Venezuela. Mem Inst Oswaldo Cruz. 2011;106(2):123–9. 57. Fugikaha É, Fornazari PA, Penhalbel R de SR, Lorenzetti A, Maroso RD, Amoras JT, et al. Molecular screening of Plasmodium sp. asymptomatic carriers among transfusion centers from Brazilian Amazon region. Rev Inst Med Trop São Paulo. 2007;49(1):1–4. 58. Torres KL, Figueiredo DV, Zalis MG, Daniel-Ribeiro CT, Alecrim W, de Fátima Ferreira-da-Cruz M. Standardization of a very specific and sensitive single PCR for detection of Plasmodium vivax in low parasitized individuals and its usefulness for screening blood donors. Parasitol Res. 2006;98(6):519–24. 49 59. Castillo C, Ramírez C. Tamización de malaria en donantes de sangre de Cali, Colombia. Biomédica. 2005;25(2):203–10. 60. Shehata N, Kohli M, Detsky A. The cost-effectiveness of screening blood donors for malaria by PCR. Transfusion (Paris). 2004;44(2):217–28. 61. Sáez-Alquézar A, Ramos AM, Di Santi SM, Branquinho MS, Kirchgatter K, Cordeiro IA, et al. Controle da malária transfusional em região endêmica e não endêmica do Brasil. Rev Soc Bras Med Trop. 1998;31(1):27–34. 62. Ferreira MU, Camargo LMA, Carvalho ME de, Ninomia RT, Garcia LAV, Santos FR dos. Prevalence and levels of IgG and IgM antibodies against Plasmodium falciparum and P. vivax in blood donors from Rondonia, Brazilian Amazon. Mem Inst Oswaldo Cruz. 1993;88(2):263–9. 63. Nunez L, Linares J, Perez AH. [Seroprevalence of antibodies against Plasmodium falciparum in volunteer donors from various cities in Venezuela]. Sangre (Barc). 1992;37(2):141–3. 64. de Morales PO, Duque E, Espinal CA, Guerra P. Aplicación del método ELISA para la detección de anticuerpos maláricos en donantes de sangre. Bol Oficina Sanit Panam. 1986;101(4):348–54. 65. de Morales PO, Espinal CA. Detección de anticuerpos antiplasmodium por ELISA en donantes de sangre. Biomédica. 1982;2(2):57–62. 66. Sulzer AJ, Wilson M. The indirect fluorescent antibody test for the detection of occult malaria in blood donors. Bull World Health Organ. 1971;45(3):375. 67. Cullen KA, Arguin PM. Malaria surveillance—United States, 2011. MMWR Surveill Summ. 2013;62(5):1–17. 68. Echeverri D, Barreto DK, Osorio L, Cortés A, Martínez E. Malaria por Plasmodium vivax transmitida por transfusión de un donante asintomático a un recién nacido prematuro. Biomédica. 2012;32:8–12. 69. Mali S, Tan, Katherine, Arguin PM. Malaria surveillance–United States, 2009. MMWR Surveill Summ. 2011;60(SS03):1–15. 70. Gonzalez C, Layon A, Arguin P, Barnwell J, Wilkins P, Leiby DA, et al. Transfusion-transmitted falciparum malaria from an asymptomatic donor. In: Transfusion. WILEY-BLACKWELL COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA; 2011. p. 197A – 197A. 71. Mali S, Steele S, Slutsker L, Arguin PM, others. Malaria surveillance–United States, 2007 [Internet]. Department of Health & Human Services, Centers for Disease Control and Prevention; 2009 [citado 12 de setembro de 2015]. Recuperado de: http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5802a1.htm?s 50 72. Kirchgatter K, Nogueira SL, Padilha A, Curado I, Boulos M, Di Santi SM. Lethal malaria caused by Plasmodium malariae in an asplenic patient in Brazil. BMJ. 2005;331(7516):576b. 73. Di Santi SM, Carvalho ME, Costa MJ, Kirchgatter K, Pereira BF, Toniolo C, et al. Malária transfusional causada por Plasmodium malariae transmitido por doador assintomático infectado na Mata Atlântica do Estado de São Paulo. In: XL Congresso da Sociedade Brasileira de Medicina Tropical e I Encontro de Medicina Tropical do Cone Sul. 2005. p. 6–10. 74. Shah S, Filler S, Causer LM, Rowe AK, Bloland PB, Barber AM, et al. Malaria surveillance–United States, 2002. Morb Mortal Wkly Rep Surveill Summ Wash DC 2002. 2004;53(1):21–34. 75. CDC C for D. Probable transfusion-transmitted malaria–Houston, Texas, 2003. MMWR Morb Mortal Wkly Rep. 2003;52(44):1075. 76. Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med. 2001;344(26):1973–8. 77. Slinger R, Giulivi A, Bodie-Collins M, Hindieh F, John RS, Sher G, et al. Transfusion-transmitted malaria in Canada. Can Med Assoc J. 2001;164(3):377–9. 78. MacArthur JR, Levin AR, Mungai M, Roberts J, Barber AM, Bloland PB, et al. Malaria surveillance—United States, 1997. CDC Surveill Summ MMWR March. 2001;30:50. 79. Mungai M, Roberts J, Barber AM, Williams HA, Ruebush TK, Chang MH. Malaria surveillance—United States, 1996. CDC Surveill Summ March 23 MMWR. 2001;50:1–22. 80. Williams HA, Roberts J, Kachur SP, Barber AM, Barat LM, Bloland PB, et al. Malaria surveillance—United States, 1995. MMWR CDC Surveill Summ. 1999;48(1):1–23. 81. CDC C for D. Transfusion-transmitted malaria–Missouri and Pennsylvania, 1996-1998. MMWR Morb Mortal Wkly Rep. 1999;48(12):253. 82. Kachur SP, Reller ME, Barber AM, Barat LM, Koumans EH, Parise ME, et al. Malaria surveillance–United States, 1994. MMWR CDC Surveill Summ Morb Mortal Wkly Rep CDC Surveill Summ Dis Control. 1997;46(5):1–18. 83. Barat LM, Zucker JR, Barber AM, Parise ME, Paxton LA, Roberts J, et al. Malaria surveillance—United States, 1993. MMWR CDC Surveill Summ. 1997;46(2):27–47. 51 84. Soto Cáceres V, Cumpa Suyón M. Malaria intrahospitalaria en el Hospital Nacional IPSS Almanzor Aguinaga Asenjo de Chiclayo. Bol Soc Peru Med Interna. 1993;6(4):127–8. 85. de Andrade JCR, Wanderley DMV. Malária induzida no estado de São Paulo, Brasil. Rev Soc Bras Med Trop. 1991;24(3):157–61. 86. Insausti CL de, Torres J. Malaria inducida en Venezuela, un problema recurrente: reporte de dos casos por transfusión de derivados sanguíneos. Bol Venez Infectol. 1990;2(1):41–2. 87. Ríos Fabra A, Vargas Arenas RE, Wuani Ettedgui H, Linares J. Paludismo posttransfusional: reporte de un caso y revisión de la literatura. Arch Hosp Vargas. 1986;28(3/4):165–8. 88. Olivares Lopez F, Cruz Carranza G, Pérez Rodríguez E, Camacho Gutiérrez GR. Paludismo inducido por transfusión de sangre. Análisis de 44 casos. Rev Medica Mex. 1985;23(2):153–7. 89. CDC C for DC. Transfusion malaria: serologic identification of infected donors– Pennsylvania, Georgia. MMWR Morb Mortal Wkly Rep. 1983;32(17):222. 90. Yarrish RL, Janas JS, Nosanchuk JS, Steigbigel RT, Nusbacher J. Transfusion malaria: treatment with exchange transfusion after delayed diagnosis. Arch Intern Med. 1982;142(1):187–8. 91. Joishy S, Lopez C. Transfusion-induced malaria in a splenectomized ßthalassemia major patient and review of blood donor screening methods. Am J Hematol. 1980;8:221–9. 92. Garfield MD, Ershler WB, Maki DG. Malaria transmission by platelet concentrate transfusion. JAMA. 1978;240(21):2285–6. 93. Sawyer DM, Wadsworth LD. Plasmodium ovale malaria in Canada following transfusion. Can Med Assoc J. 1977;117(8):923. 94. Olivares L, Perez R, Vargas D, Camacho G. Paludismo inducido. Olivares, LF; Perez, RG; Vargas, DR; Camacho, GM: Salud Púb Méx. 1977;19:701. 95. Najem GR, Sulzer AJ. Transfusion-Induced Malaria from an Asymptomatic Carrier. Transfusion (Paris). 1976;16(5):473–6. 96. Maulitz RM, Marr JS, Shookhoff HB. Transfusion malaria as a consequence of the 1974 war between Turkey and Greece–two cases. Am J Trop Med Hyg. 1976;25(1):1–4. 97. Alvarez C, Rodriguez E, Diaz H. Paludismo transmitido por transfusión de sangre em los niños. Salud Púb Méx. 1974;15:213. 52 98. Seeler RA, Miller RA, Lin C-H, Lin S-K. Transfusion-induced malaria: Plasmodium vivax in a 5-month-old child. Am J Dis Child. 1973;125(1):132–3. 99. Dover AS, Guinee VF. Malaria transmission by leukocyte component therapy. JAMA. 1971;217(12):1701–2. 100. Arriaga J, Ramirez I, Ruiloba B, Ortega P. Paludismo postransfusional. Arch Inst Cardiol Méx. 1970;40:396. 101. Brooks MH, Barry KG. Fatal transfusion malaria. Blood. 1969;34(6):806–10. 102. Fisher G, Schultz M. Unusual host-parasite relationship in blood-donors responsible for transfusion-induced falciparum malaria. The Lancet. 1969;294(7623):716–8. 103. Chojnacki RE, Brazinsky JH, Barrett Jr O. Transfusion-introduced falciparum malaria. N Engl J Med. 1968;279(18):984. 104. Fischer WJ, York CL. Quartan Malaria Occurring Subsequent to a Blood Transfusion: Report of a Case. N Engl J Med. 1946;235(12):411–3.
dc.rights.driver.fl_str_mv Atribuição-NãoComercial-SemDerivados 3.0 Brasil
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Atribuição-NãoComercial-SemDerivados 3.0 Brasil
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade do Estado do Amazonas
Brasil
UEA
PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS APLICADAS Á HEMATOLOGIA
publisher.none.fl_str_mv Universidade do Estado do Amazonas
Brasil
UEA
PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS APLICADAS Á HEMATOLOGIA
dc.source.none.fl_str_mv reponame:Repositório Institucional da Universidade do Estado do Amazonas (UEA)
instname:Universidade do Estado do Amazonas (UEA)
instacron:UEA
instname_str Universidade do Estado do Amazonas (UEA)
instacron_str UEA
institution UEA
reponame_str Repositório Institucional da Universidade do Estado do Amazonas (UEA)
collection Repositório Institucional da Universidade do Estado do Amazonas (UEA)
repository.name.fl_str_mv Repositório Institucional da Universidade do Estado do Amazonas (UEA) - Universidade do Estado do Amazonas (UEA)
repository.mail.fl_str_mv bibliotecacentral@uea.edu.br
_version_ 1816701123495460864

Registros relacionados